# Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese

> **NCT03714737** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 1950 (actual)

## Conditions studied

- Vaccine

## Interventions

- **BIOLOGICAL:** experimental vaccine
- **BIOLOGICAL:** Positive control vaccine 1
- **BIOLOGICAL:** Positive control vaccine 2

## Key facts

- **NCT ID:** NCT03714737
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-12
- **Primary completion:** 2017-09-11
- **Final completion:** 2018-09-06
- **Target enrollment:** 1950 (ACTUAL)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714737, "Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03714737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*